Skip to content

Clinical trials

Completed Phase 3 Kidney Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Diseases Phase: Phase 3 Status: Completed Clear all

70 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20033
20049
20053
20066
20075
20083
20093
20105
20111
20124
20132
20143
20154
20162
20173
20181
20192
20211
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed70

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen11
AbbVie2
AstraZeneca2
Bayer2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2
Kaiser Permanente2
Mayo Clinic2
Novartis2
OPKO IP Holdings II, Inc.2
Panion & BF Biotech Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Diseases70
Renal Insufficiency, Chronic25
Renal Insufficiency13
Kidney Failure, Chronic12
Anemia11
Diabetes Mellitus, Type 25
Diabetic Nephropathies5
Hypertension5
Hyperparathyroidism4
Vitamin D Deficiency4

Trials

Showing 1 to 25 of 70. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.